BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 9439839)

  • 21. Pituitary adenylate cyclase-activating polypeptide expression and modulation of neuronal excitability in guinea pig cardiac ganglia.
    Braas KM; May V; Harakall SA; Hardwick JC; Parsons RL
    J Neurosci; 1998 Dec; 18(23):9766-79. PubMed ID: 9822736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs.
    Rawlings SR; Piuz I; Schlegel W; Bockaert J; Journot L
    Endocrinology; 1995 May; 136(5):2088-98. PubMed ID: 7720658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
    Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
    Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pituitary adenylate-cyclase-activating polypeptide (PACAP) binding sites and PACAP/vasoactive intestinal polypeptide receptor expression in human pituitary adenomas.
    Oka H; Jin L; Reubi JC; Qian X; Scheithauer BW; Fujii K; Kameya T; Lloyd RV
    Am J Pathol; 1998 Dec; 153(6):1787-96. PubMed ID: 9846969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of pituitary adenylate cyclase-activating polypeptide on facial nerve recovery in the Guinea pig.
    Kimura H; Kawatani M; Ito E; Ishikawa K
    Laryngoscope; 2003 Jun; 113(6):1000-6. PubMed ID: 12782812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
    Barberi M; Muciaccia B; Morelli MB; Stefanini M; Cecconi S; Canipari R
    Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pituitary adenylate cyclase-activating polypeptides directly stimulate sympathetic neuron neuropeptide Y release through PAC(1) receptor isoform activation of specific intracellular signaling pathways.
    Braas KM; May V
    J Biol Chem; 1999 Sep; 274(39):27702-10. PubMed ID: 10488112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) stimulate interleukin-6 production through the third subtype of PACAP/VIP receptor in rat bone marrow-derived stromal cells.
    Cai Y; Xin X; Shim GJ; Mokuno Y; Uehara H; Yamada T; Agui T; Matsumoto K
    Endocrinology; 1997 Jun; 138(6):2515-20. PubMed ID: 9165043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pituitary adenylate cyclase activating polypeptide innervation of the rat female reproductive tract and the associated paracervical ganglia: effect of capsaicin.
    Fahrenkrug J; Hannibal J
    Neuroscience; 1996 Aug; 73(4):1049-60. PubMed ID: 8809823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autocrine expression and ontogenetic functions of the PACAP ligand/receptor system during sympathetic development.
    DiCicco-Bloom E; Deutsch PJ; Maltzman J; Zhang J; Pintar JE; Zheng J; Friedman WF; Zhou X; Zaremba T
    Dev Biol; 2000 Mar; 219(2):197-213. PubMed ID: 10694416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced production of pituitary adenylate-cyclase-activating polypeptide by 1, N6-dibutyryladenosine 3',5'-monophosphate, phorbol 12-myristate 13-acetate and by the polypeptide itself in human neuroblastoma cells, IMR-32.
    Suzuki N; Harada M; Hosoya M; Fujino M
    Eur J Biochem; 1994 Jul; 223(1):147-53. PubMed ID: 7913440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pituitary adenylate cyclase activating polypeptide is expressed in autonomic neurons.
    Mulder H; Uddman R; Moller K; Elsås T; Ekblad E; Alumets J; Sundler F
    Regul Pept; 1995 Sep; 59(1):121-8. PubMed ID: 12506422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ontogeny of pituitary adenylate cyclase-activating polypeptide (PACAP) and its binding sites in the rat brain.
    Masuo Y; Tokito F; Matsumoto Y; Shimamoto N; Fujino M
    Neurosci Lett; 1994 Mar; 170(1):43-6. PubMed ID: 7913744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Properties of the pituitary adenylate cyclase-activating polypeptide I and II receptors, vasoactive intestinal peptide1, and chimeric amino-terminal pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal peptide1 receptors: evidence for multiple receptor states.
    Van Rampelbergh J; Gourlet P; De Neef P; Robberecht P; Waelbroeck M
    Mol Pharmacol; 1996 Dec; 50(6):1596-604. PubMed ID: 8967982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative distribution of pituitary adenylate cyclase-activating polypeptide (PACAP) binding sites and PACAP receptor mRNAs in the rat brain during development.
    Basille M; Vaudry D; Coulouarn Y; Jegou S; Lihrmann I; Fournier A; Vaudry H; Gonzalez B
    J Comp Neurol; 2000 Oct; 425(4):495-509. PubMed ID: 10975876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Photoaffinity labeling analysis of the interaction of pituitary adenylate-cyclase-activating polypeptide (PACAP) with the PACAP type I receptor.
    Cao YJ; Kojro E; Gimpl G; Jasionowski M; Kasprzykowski F; Lankiewicz L; Fahrenholz F
    Eur J Biochem; 1997 Mar; 244(2):400-6. PubMed ID: 9119005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland.
    Mazzocchi G; Malendowicz LK; Neri G; Andreis PG; Ziolkowska A; Gottardo L; Nowak KW; Nussdorfer GG
    Int J Mol Med; 2002 Mar; 9(3):233-43. PubMed ID: 11836629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pituitary adenylate cyclase activating peptide and its receptors are expressed in human neuroblastomas.
    Vertongen P; Devalck C; Sariban E; De Laet MH; Martelli H; Paraf F; Hélardot P; Robberecht P
    J Cell Physiol; 1996 Apr; 167(1):36-46. PubMed ID: 8698838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cloning and functional characterization of a third pituitary adenylate cyclase-activating polypeptide receptor subtype expressed in insulin-secreting cells.
    Inagaki N; Yoshida H; Mizuta M; Mizuno N; Fujii Y; Gonoi T; Miyazaki J; Seino S
    Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2679-83. PubMed ID: 8146174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypophysiotropic action of pituitary adenylate cyclase-activating polypeptide (PACAP) in the goldfish: immunohistochemical demonstration of PACAP in the pituitary, PACAP stimulation of growth hormone release from pituitary cells, and molecular cloning of pituitary type I PACAP receptor.
    Wong AO; Leung MY; Shea WL; Tse LY; Chang JP; Chow BK
    Endocrinology; 1998 Aug; 139(8):3465-79. PubMed ID: 9681497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.